French oak extract may significantly improve symptoms of mononucleosis, says new study

March 15, 2019

French oak extract significantly reduced symptoms of mononucleosis, such as fatigue, malaise, and nausea. 

A new study published in Minerva Pediatrica1 shows that supplementation with French oak extract Robuvit (Horphag Research; Hoboken, NJ) significantly improved symptoms of mononucleosis. In the study, 50 patients with confirmed cases of mononucleosis were placed into a standard management group consisting of vitamin B, C, and D, balanced healthy diet, regular sleeping schedule, physical activity, and 2 mg copper, or standard management plus 300 mg of Robuvit per day, for four weeks.

After four weeks, it was observed that subjects supplementing with Robuvit experience a significant reduction in the rate of symptoms compared to standard management alone. Specifically, subjects taking Robuvit experiences significant reductions in abdominal pain, nausea, fatigue, malaise, and swollen neck glands. Supplementation with Robuvit also allowed subjects to be more productive, reducing absences from school and work by four days, compared to standard management alone. Decrease in fatigue, note the researchers, strongly correlated with a decrease, in some cases, normalization of oxidative stress levels. 
 

References:

1. Hu S et al. "Mononucleosis-related fatigue: supplementary management with Robuvit." Minerva Pediatrica, vol. 70, no. 5 (2018): 425-429